THERAPY AND PREVENTION VALVULAR HEART DISEASE Results of triple valve replacement in 91 patients: perioperative mortality and long-term follow-up

patients with NYHA class IV symptoms, perioperative mortality was 44%, and in those with milder symptoms, it was 8 % (p <.0001). The median follow-up was 7.5 years (range, 6 weeks to 20 years). Cumulative survival, which was calculated taking into consideration perioperative mortality, was 64